Answers are grounded in this paper and cite their sources.
The link between melanoma and spina bifida merits investigation. Spina bifida is a neurocristopathy with an increase in malignancy, notably bladder cancer. Melanoma is a neurocristopathy also and the correlation has been postulated. Previously regarded as a paediatric condition, two-thirds of patients with spina bifida are now adults and their care needs are more complex. Myelomeningocele, commonly known as spina bifida, is a congenital birth defect in which the spinal cord does not develop properly due to incomplete closure of the neural tube at 28 days of gestation. Spina bifida is a condition which affects approximately one in every 1000 children born per year in Ireland. A 54-year-old female with spina bifida was admitted for treatment of cellulitis of her left lower leg. Tissue Viability Advanced Nurse Practitioner noted a dark nevus on her left lower leg. The patient was unaware of any changes in the lesion. She had a history of multiple surgeries for bladder and bowel reconstruction, as well as frequent urinary tract infections and pressure sores. On examination, a 20 mm circumferential pigmented lesion with irregular borders and asymmetrical shape was noted on her left lower leg. She underwent an excision which revealed melanoma in situ, pTis with a further wide local excision postdiscussion at multidisciplinary meeting. She was advised regarding photoprotection and is under dermatological surveillance, and in keeping with NICE guidelines her vitamin D level was checked and supplemented.1 Melanoma is a malignant tumour that arises from epidermal melanocytes. Spina bifida, like malignant melanoma, is a neurocristopathy. This case report highlights the importance of skin checks and sun protection for patients with spina bifida. A survey in Canada revealed outpatient service use was high (1.0 visit per month) but most individuals did not have a primary care physician.2 In addition, nonambulatory status may lead to incomplete examination of certain body areas, such as pelvis and areas under braces. This underscores the need for increased awareness of the risk of skin cancer in this population and the importance of early detection and management of skin cancers. There has been a paucity of case reports on malignant melanoma in patients with spina bifida which limits the correlation between the two at present. Patients with spina bifida undertake frequent radiological surveillance and are likely to have a greater exposure to radiation than the average person during childhood.3, 4 Exposure to radiation introduces a risk of malignancy based on cumulative effective dose, with risk for exposures exceeding 50 milliSievert derived primarily from the Life Span Study.5 There is an elevated rate of bladder cancer in patients with spina bifida have an increased risk of bladder with 2.5% cumulative incidence in those with neurogenic bladder.6 Koutros et al. demonstrated a strong association between risk of bladder cancer and melanoma (Odds Ratio = 1.9, 95% Confidence Interval 1.02–3.6).7 Melanomas and bladder tumours display comparable cell-cycle pathway, DNA damage response and PI3-kinase pathway alterations as well as some shared germline genetic susceptibility influencing risk for developing these tumours (on chromosomes 3, 5, 6 and 9).8-10 This case reinforces the link between the development of melanoma and spina bifida. Patients with spina bifida are surviving longer and these complexities shall arise. Large-scale research is indicated to define the link between malignant melanoma and spina bifida considering their origins as neurocristopathies. Melanoma screening may be indicated in this high-risk group. Diligence with sun protection and full skin examination is important for patients with spina bifida as well as vitamin D maintenance. Sarah O'Mahony wrote the paper, collected the data, and analysed the data. Lisa Murphy, Marta Costa Blasco, Claire Doyle, Orla McFeelycF and Madonna Andrawis collected and analysed the data. Anne Marie Tobin conceived the design and edited the paper. Open access funding provided by IReL. The authors declare no conflict of interest. All patients in this manuscript have given written informed consent for participation in the study and the use of their deidentified, anonymized, aggregated data and their case details (including photographs) for publication. Ethical Approval: not applicable.
No takes yet. Share an insight, caveat, or question.
O’Mahony et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: